Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

Published:2012-09-13 Issue:1 Volume:12 Page:
ISSN:1472-6823
Container-title:BMC Endocrine Disorders
language:en
Short-container-title:BMC Endocr Disord

Author:

Tomaschitz Andreas,Fahrleitner-Pammer Astrid,Pieske Burkert,Verheyen Nicolas,Amrein Karin,Ritz Eberhard,Kienreich Katharina,Horina Jörg H,Schmidt Albrecht,Kraigher-Krainer Elisabeth,Colantonio Caterina,Meinitzer Andreas,Pilz Stefan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1186/1472-6823-12-19/fulltext.html

Reference49 articles.

1. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ: Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006, 21 (1): 171-177.

2. Ogard CG, Sondergaard SB, Vestergaard H, Jakobsen H, Nielsen SL: Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism. World J Surg. 2005, 29 (7): 914-916. 10.1007/s00268-005-7740-1.

3. Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, März W: Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J. 2010, 31 (13): 1591-1598. 10.1093/eurheartj/ehq109.

4. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K: Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009, 119 (21): 2765-2771. 10.1161/CIRCULATIONAHA.108.808733.

5. Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, März W: Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen risk and cardiovascular health (LURIC) study. Eur Heart J. 2010, 31 (10): 1237-1247. 10.1093/eurheartj/ehq019.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review on Diabetes Associated Cardiovascular Complications - The Vitamin D Perspective;Cardiovascular & Hematological Disorders-Drug Targets;2019-07-05

2. Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data;Hormone and Metabolic Research;2018-05

3. Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism – The randomized, placebo-controlled EPATH trial;Bone;2017-12

4. Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial;PLOS ONE;2017-04-13

5. Dysfunctional immunometabolic effects of vitamin D deficiency, increased cardiometabolic risk. Potential epidemiological alert in America?;Endocrinología, Diabetes y Nutrición (English ed.);2017-03